These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8568590)

  • 41. Discrimination of human small cell and non-small cell lung tumors by a panel of monoclonal antibodies.
    Tong AW; Lee JC; Stone MJ
    J Natl Cancer Inst; 1986 Nov; 77(5):1023-33. PubMed ID: 3022055
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distinct expression patterns of CD44 isoforms during human lung development and in pulmonary fibrosis.
    Kasper M; Günthert U; Dall P; Kayser K; Schuh D; Haroske G; Müller M
    Am J Respir Cell Mol Biol; 1995 Dec; 13(6):648-56. PubMed ID: 7576702
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic utility of CD44 standard, CD44v6, and CD44v3-10 expression in adenocarcinomas presenting in serous fluids.
    Afify A; Pang L; Howell L
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):446-50. PubMed ID: 18091389
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical significance of CD44s, CD44v3 and CD44v6 in breast cancer.
    Wu XJ; Li XD; Zhang H; Zhang X; Ning ZH; Yin YM; Tian Y
    J Int Med Res; 2015 Apr; 43(2):173-9. PubMed ID: 25571897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preferential histiotypic expression of CD44-isoforms in human lung cancer.
    Wimmel A; Schilli M; Kaiser U; Havemann K; Ramaswamy A; Branscheid D; Kogan E; Schuermann M
    Lung Cancer; 1997 Mar; 16(2-3):151-72. PubMed ID: 9152947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
    Tran TA; Kallakury BV; Sheehan CE; Ross JS
    Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of cell adhesion molecules in lung cancer cell lines.
    Horn S; Moersig W; Moll R; Oelert H; Lorenz J
    Exp Toxicol Pathol; 1996 Nov; 48(6):535-40. PubMed ID: 8954343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunohistochemical and ultrastructural study of mixed small cell/large cell carcinoma of the lung. Expression of Sialyl LeX-i antigens and scarcity of neuroendocrine characteristics.
    Yokose T; Asami H; Ito Y
    Acta Pathol Jpn; 1991 Jul; 41(7):540-51. PubMed ID: 1661556
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens.
    Nicholson SA; Beasley MB; Brambilla E; Hasleton PS; Colby TV; Sheppard MN; Falk R; Travis WD
    Am J Surg Pathol; 2002 Sep; 26(9):1184-97. PubMed ID: 12218575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Variant expression of CD44 in preneoplastic lesions of the lung.
    Wimmel A; Kogan E; Ramaswamy A; Schuermann M
    Cancer; 2001 Sep; 92(5):1231-6. PubMed ID: 11571737
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum CD44 levels in patients with non-small cell lung cancer and their relationship with clinicopathological features.
    Takigawa N; Segawa Y; Mandai K; Takata I; Fujimoto N
    Lung Cancer; 1997 Oct; 18(2):147-57. PubMed ID: 9316006
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of CD44 and CD44v6 expression in patients with non-small cell lung cancer: meta-analysis.
    Jiang H; Zhao W; Shao W
    Tumour Biol; 2014 Aug; 35(8):7383-9. PubMed ID: 24913707
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of CD44 in human lung tumors.
    Penno MB; August JT; Baylin SB; Mabry M; Linnoila RI; Lee VS; Croteau D; Yang XL; Rosada C
    Cancer Res; 1994 Mar; 54(5):1381-7. PubMed ID: 7509720
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High frequency expressions of CD44 standard and variant forms in non-small cell lung cancers, but not in small cell lung cancers.
    Kondo K; Miyoshi T; Hino N; Shimizu E; Masuda N; Takada M; Uyama T; Monden Y
    J Surg Oncol; 1998 Nov; 69(3):128-36. PubMed ID: 9846498
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Relationship of the expression of CD44v6 and paxillin to the prognosis of non-small cell lung carcinoma].
    Zuo W; Li H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):484-5. PubMed ID: 12910696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of proliferating cell nuclear antigen and CD44 variant isoforms in the primary and metastatic sites of nonsmall cell lung carcinoma with intrapulmonary metastases.
    Fukuse T; Hirata T; Naiki H; Hitomi S; Wada H
    Cancer; 1999 Oct; 86(7):1174-81. PubMed ID: 10506701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Expression of CD44 variant exon 6 in lung cancers].
    Wang FL; Wei LX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):401-2. PubMed ID: 12940087
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuroendocrine and epithelial markers in diagnostic bronchial lung cancer biopsy specimens.
    Burnett HE; Zakhour HD; Walker C
    Eur J Cancer; 1992; 28A(4-5):853-5. PubMed ID: 1381930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunohistochemical study of P-glycoprotein distribution in lung cancer.
    Pujol JL; Simony J; Gautier V; Marty-Ané C; Pujol H; Michel FB
    Lung Cancer; 1993 Oct; 10(1-2):1-12. PubMed ID: 7915180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Expression of CD44 standard and CD44 variant 6 in human lung cancer].
    Ochiai S; Nakanishi Y; Mizuno K; Hashimoto S; Inutsuka S; Kawasaki M; Yatsunami J; Hara N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Nov; 35(11):1179-85. PubMed ID: 9493443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.